Ads
related to: is raycon actually good for vision loss and tinnitus relief medicine list
Search results
Results From The WOW.Com Content Network
Ophthalmology. Toxic and nutritional optic neuropathy is a group of medical disorders defined by visual impairment due to optic nerve damage secondary to a toxic substance and/or nutritional deficiency. The causes of these disorders are various, but they are linked by shared signs and symptoms, which this article will describe.
Involuntary muscle contractions. Abnormal coordination. Syncope (fainting) Blurred vision. Dyspnoea (shortness of breath) Tinnitus (ringing in the ears) Migraine. Stevens–Johnson syndrome / toxic epidermal necrolysis (potentially fatal skin reactions) Motorial weakness.
Ototoxic medication. Ototoxicity is defined as the toxic effect on the functioning of the inner ear, which may lead to temporary or permanent hearing loss (cochleotoxic) and balancing problems (vestibulotoxic). [1] Drugs or pharmaceutical agents inducing ototoxicity are regarded as ototoxic medications .
Tinnitus retraining therapy ( TRT) is a form of habituation therapy designed to help people who experience tinnitus —a ringing, buzzing, hissing, or other sound heard when no external sound source is present. Two key components of TRT directly follow from the neurophysiological model of tinnitus: Directive counseling aims to help the sufferer ...
For premium support please call: 800-290-4726 more ways to reach us
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
Bao, a longtime tinnitus sufferer and a representative of the American Tinnitus Association's scientific advisory board, has studied tinniuts for more than a decade. A Facebook group of people who ...
At least five of the other drugs on the initial government list, including Merck & Co's diabetes drug Januvia and Amgen's rheumatoid arthritis treatment Enbrel, are expected to face generic ...